Show simple item record

dc.contributor.advisorTrgovcich, Joanne
dc.creatorShah, Niti
dc.date.accessioned2014-12-30T17:53:09Z
dc.date.available2014-12-30T17:53:09Z
dc.date.issued2009-06
dc.identifier.urihttp://hdl.handle.net/1811/63972
dc.descriptionDean's Undergraduate Research Funden
dc.description.abstractHuman cytomegalovirus (HCMV) causes severe diseases in those with immature or compromised immune systems, including transplant patients and congenitally infected infants. Even in normal healthy adults, this virus has been linked to chronic diseases such as atherosclerosis and cancer. Research has shown that HCMV is able to utilize a range of cellular signaling pathways to promote its replication. Sphingolipid signaling impacts several important physiological processes, including cell growth, migration, and survival (1). Based on this, we hypothesized that sphingolipids are regulated by virus infection. When we examined the accumulation of sphingolipids in cells infected with HCMV, we observed that sphingolipid metabolism is dynamically regulated according to the temporal phase of infection. In this thesis, we set out to study the consequences of this regulation. In these studies, we found that cells exposed to bioactive sphingolipids before infection show reduced synthesis of viral proteins. These findings provide evidence that activation of sphingolipid signaling pathways may play a role in cellular antiviral defense.en
dc.language.isoen_USen
dc.publisherThe Ohio State Universityen
dc.relation.ispartofseriesThe Ohio State University. College of Biological Sciences Honors Theses; 2009en
dc.subjectSphingolipidsen
dc.subjectAntiviral Activityen
dc.titleAntiviral Activity of Bioactive Sphingolipidsen
dc.typeThesisen
dc.description.embargoA five-year embargo was granted for this item.en


Files in this item

Thumbnail

Items in Knowledge Bank are protected by copyright, with all rights reserved, unless otherwise indicated.

This item appears in the following Collection(s)

Show simple item record